Global private equity and venture capital news and research

Private equity consortium increases offer for Biomet to $11.4bn

8 Jun 2007

The board of directors of Warsaw, Indiana-headquartered Biomet, a specialist in the orthopedic and musculoskeletal product industry, has unanimously recommended to shareholders an increased offer from a private equity consortium including The Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Co. and TPG to acquire Biomet for $46 per share in cash, or an equity value of $11.4bn.

Sorry, to get access to this you need to subscribe for free.

In order to view more content, sign-up to our free daily newsletter.

If you would like to read the premium stories, have complete access to our breaking news and Limited Partner magazine you need to become a Premium Subscriber.

Subscribe to AltAssets today

Login to AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016